DPhG-Vortrag: Let the sunshine in! Development, approval and benefit assessment of afamelanotide, the first drug for treating erythropoietic protoporphyria
PD Dr. Jasmin Barman-Aksözen,
University of Zurich, Municipal Hospital Zurich, Switzerland
| Wann |
17:15
18:00
24.01.2024 von bis |
|---|---|
| Wo | Hörsaal - Pharmazie, Hermann-Herder-Str.7 |
| Termin übernehmen |
vCal
iCal
|
Gastgeberin: Prof. Dr. Gunhild Layer